Latest information on COVID-19
Support teaching, research, and patient care.
Andrea Lora Kossler, MD, is Assistant Professor of Ophthalmology at Stanford University School of Medicine and Director of the Ophthalmic Plastic, Reconstructive Surgery and Orbital Oncology Service at the Byers Eye Institute at Stanford. She specializes in plastic and reconstructive surgery of the forehead, mid-face, and eyes and has a special interest in aesthetic medicine and thyroid eye disease. Andrea has been in practice for over 8 years and treats adults and children with oculoplastic conditions. Dr. Kossler’s research interests include thyroid eye disease, orbital oncology, and neurostimulation for ocular surface disease.Andrea is the Co-Director of the Thyroid Eye Disease Center at Stanford Hospital Center where she works together with a multidisciplinary team including an endocrinologist and radiation oncologist to provide patient centered care to patients diagnosed with thyroid eye disease. She is also the Director of the Stanford Aesthetic Eye Surgery Center where she specializes in cosmetic surgery and aesthetic treatments of the eyelids and face. She earned her medical degree from Georgetown University School of Medicine where she graduated summa cum laude and valedictorian of her class. She holds a Bachelor of Science degree from the University of Florida where she graduated with highest honors. She completed her internship in internal medicine at the Mount Sinai Medical Center and her residency in Ophthalmology at the number one ranked Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine. She continued at the Bascom Palmer Eye Institute to complete a fellowship in Ophthalmic Plastic and Reconstructive surgery and served as a Clinic Instructor of Ophthalmology.Outside of work Andrea enjoys time with her husband, two daughters and dog Roxy.
Thyroid Eye Disease<br/>Adenoid Cystic Carcinoma of the Lacrimal Gland<br/>Lacrimal Gland Stimulation for the Treatment of Dry Eyes<br/>Neurostimulation<br/>Orbital Tumors<br/>Floppy Eyelid Syndrome and Obstructive Sleep Apnea
Surgical Idiopathic Intracranial Hypertension Treatment Trial
Randomized trial of adults (≥18 years old) with idiopathic intracranial hypertension and
moderate to severe visual loss without substantial recent treatment who are randomly assigned
to (1) medical therapy, (2) medical therapy plus ONSF, or (3) medical therapy plus VPS. The
primary outcome is visual field mean deviation change at first of Month 6 (26 weeks) or time
of treatment failure of the eligible eye(s), followed by a continuation study to assess time
to treatment failure. The determination of eligible eye(s) is based on meeting the
eligibility criteria at baseline.
View full details
The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.
The purpose of this study is to evaluate the potential secondary beneficial effect of
prostaglandin analogues (PA) treatment in thyroid eye disease (TED) patients. This study aims
to determine if PA would change the course of the orbitopathy in TED patients by altering the
progression of the common features of TED, including fatty hypertrophy, proptosis, eyelid
retraction and optic nerve compression. The eyes with thyroid eye disease and elevated
intraocular pressure will be randomised to the PA treatment and the other eye will serve as a
control eye and will be treated with Timolol.
Stanford is currently not accepting patients for this trial.
For more information, please contact Barbara Bartlett, 650-724-9259.